Influenza virus vaccine
- PDF / 168,927 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 79 Downloads / 194 Views
1 S
Anaphylaxis: case report In a review of 12320 reports reported to Vaccine Adverse Event Reporting System (VAERS) database in USA from 1 January 2011 to 30 June 2019, an elderly patient [sex and exact age not stated] was described, who developed anaphylaxis following vaccination with influenza virus vaccine [trivalent inactivated influenza vaccine; supplied by Sanofi Pasteur] at an unspecified high-dose [route and time to reaction onset not stated]. The Brighton level was 2 [outcome not stated]. Moro PL, et al. Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019. Vaccine 38: 803499670 5923-5926, No. 37, 18 Aug 2020. Available from: URL: http://doi.org/10.1016/j.vaccine.2020.07.007
0114-9954/20/1821-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 12 Sep 2020 No. 1821
Data Loading...
